RELMADA THERAPEUTICS, INC. RLMD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-03
RELMADA THERAPEUTICS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| TRAVERSA SERGIO | Chief Executive Officer | 2025-12-15 | Buy | 27,500 | $4.12 |
| Shenouda Maged | Chief Financial Officer | 2025-12-15 | Buy | 11,665 | $4.12 |
| Shenouda Maged | Chief Financial Officer | 2025-11-05 | Buy | 500,000 | $2.20 |
| Ence Chuck | CAO and COO | 2025-11-05 | Buy | 136,000 | $2.20 |
| TRAVERSA SERGIO | Chief Executive Officer | 2025-11-05 | Buy | 272,500 | $2.20 |
Source: SEC EDGAR filings · CIK 0001553643 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.